Grant: Master's Award: Canada Graduate Scholarships
University of Toronto
$17,500.00
Ocular drug delivery though polymeric devices
EF 2013-14
Résumé
An issue plaguing ophthalmic health professional is the effective delivery of pharmaceuticals to the anterior segment of the eye. Eye drops are a current method of drug delivery to the eye, however only 1-5% of the drug in solution reaches its target organs. A proposed method of overcoming the shortcomings of eye drops is the use of contact lenses to delivery drugs directly to the eye, increasing their bioavailability to roughly 50%. Silicone hydrogels have already been used as vision correcting contact lens materials. Their high swelling capability and high oxygen permeability make them suitable materials for use in the eye.
This aim of this research is to design silicone hydrogel materials that could be use to deliver drugs at a controlled therapeutic rate to the anterior segment of the eye. Both hydrophilic acrylic monomers and hydrophobic silicone monomers will be employed in these lenses, along with a cross-linking agent to ensure a polymer network is formed. It is hypothesized that the main factors regulating the release of drugs from the contact lenses are the interactions between the polymer structure and the drug, and the physical entanglement of the polymer chains. The location of the drug and its affinity for the surrounding region may alter its release from the polymer network. The objective of this research is to characterize the hydrophilic and hydrophobic domains of the polymer and its properties in order to model the drug release kinetics. With this knowledge, silicone hydrogel materials could be formulated with the ability to deliver pharmaceuticals to the cornea and anterior chamber of the eye, while still maintaining properties suitable for vision correction.
In order to develop a practical means of producing drug eluding contact lenses, the release kinetics of the drug through the material must be understood. The initial stages of research will involve the characterization of the hydrogels to determine the factors that regulate drug release. Transmission electron microscopy will be used to examine the phases formed in the hydrogels. Once the phase composition has been determined, the location of the drug will be determined by time of flight secondary ion mass spectrometry. The location of the drug and its affinity for the surrounding region may alter its release from the polymer network. Different compositions of hydrophobic and hydrophilic monomers will be examined, and their drug release profiles will be recorded. Drugs with different water affinity properties will also be examined, to determine if the hydrophillicity of the drug affects its release kinetics.
Finally, different means of incorporating the drug into the lens will be examined. The release profiles of lenses created using direct synthesis and conjugation of the drug to acrylated polyethylene glycol (PEG) molecules will be compared. Conjugated PEG molecules have been used as polymer side chains because the release of the drug is dependent on the hydrolytic cleavage of the conjugation bond. This research will hopefully lead to the development of clinically relevant drug releasing contact lenses that could deliver medication to the anterior segment of the eye effectively and reduce the effects of ocular diseases.
Programme
Master's Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
311887
Name
Conant Genevieve A
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Ocular drug delivery though polymeric devices
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Biomaterials; Contact Lenses; Drug Delivery; Hydrogels; Ocular Devices; Ocular Disease; Polymer; Protein Adhesion
Abstract
An issue plaguing ophthalmic health professional is the effective delivery of pharmaceuticals to the anterior segment of the eye. Eye drops are a current method of drug delivery to the eye, however only 1-5% of the drug in solution reaches its target organs. A proposed method of overcoming the shortcomings of eye drops is the use of contact lenses to delivery drugs directly to the eye, increasing their bioavailability to roughly 50%. Silicone hydrogels have already been used as vision correcting contact lens materials. Their high swelling capability and high oxygen permeability make them suitable materials for use in the eye.
This aim of this research is to design silicone hydrogel materials that could be use to deliver drugs at a controlled therapeutic rate to the anterior segment of the eye. Both hydrophilic acrylic monomers and hydrophobic silicone monomers will be employed in these lenses, along with a cross-linking agent to ensure a polymer network is formed. It is hypothesized that the main factors regulating the release of drugs from the contact lenses are the interactions between the polymer structure and the drug, and the physical entanglement of the polymer chains. The location of the drug and its affinity for the surrounding region may alter its release from the polymer network. The objective of this research is to characterize the hydrophilic and hydrophobic domains of the polymer and its properties in order to model the drug release kinetics. With this knowledge, silicone hydrogel materials could be formulated with the ability to deliver pharmaceuticals to the cornea and anterior chamber of the eye, while still maintaining properties suitable for vision correction.
In order to develop a practical means of producing drug eluding contact lenses, the release kinetics of the drug through the material must be understood. The initial stages of research will involve the characterization of the hydrogels to determine the factors that regulate drug release. Transmission electron microscopy will be used to examine the phases formed in the hydrogels. Once the phase composition has been determined, the location of the drug will be determined by time of flight secondary ion mass spectrometry. The location of the drug and its affinity for the surrounding region may alter its release from the polymer network. Different compositions of hydrophobic and hydrophilic monomers will be examined, and their drug release profiles will be recorded. Drugs with different water affinity properties will also be examined, to determine if the hydrophillicity of the drug affects its release kinetics.
Finally, different means of incorporating the drug into the lens will be examined. The release profiles of lenses created using direct synthesis and conjugation of the drug to acrylated polyethylene glycol (PEG) molecules will be compared. Conjugated PEG molecules have been used as polymer side chains because the release of the drug is dependent on the hydrolytic cleavage of the conjugation bond. This research will hopefully lead to the development of clinically relevant drug releasing contact lenses that could deliver medication to the anterior segment of the eye effectively and reduce the effects of ocular diseases.
Competitiondate
201312
Approvedterm2
1 yr 0 mth
Pinamesdelim
Conant, Genevieve A
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~